NTRB Stock Analysis: Buy, Sell, or Hold?
NTRB - Nutriband Inc. Common Stock
$3.06
-0.03 (-0.97%)
▼
5d:
+0.99%
30d:
-13.8%
90d:
-15.0%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: May 29, 2026
0d
Get Alerted When NTRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NTRB trading at deep discount. Market pricing in -8.0% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: NTRB trading at deep discount. Market pricing in -8.0% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.49
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.41
10.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NTRB is currently trading at $3.06, which is considered oversold relative to its 30-day fair value range of $3.11 to $3.54. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.1) compared to its historical average (2.7). Remarkably, the market is currently pricing in an annual earnings decline of 8.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NTRB is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.00 (+390.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NTRB is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.00 (+390.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.11 -
$3.54
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 390.2% below Wall St target ($15.00)
Trading Range Analysis
30-Day Trading Range
$3.11 -
$3.54
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.21
Resistance Level
$3.69
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.11
Wall Street Target
$15.00
(+390.2%)
Revenue Growth (YoY)
-35.1%
Valuation Discount vs History
-8.0% cheaper
PE vs Historical
2.1 vs 2.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.0%
(market-implied from PE analysis)
1-Year Target
$2.82
(-8%)
2-Year Target
$2.59
(-15%)
3-Year Target
$2.38
(-22%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$3.05
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.1 to 2.7
Stabilization Target:
$3.92
(+27.9%)
PE Expansion Potential:
+27.9%
Share & Embed Analysis
Last updated: July 04, 2026 4:34 AM ET
Data refreshes hourly during market hours. Next update: 5:34 AM
Data refreshes hourly during market hours. Next update: 5:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
